Heparin-induced thrombocytopenia in a patient treated with fondaparinux.
Ratuapli
Shiva K
SK
Department of Medicine, Banner Estrella Medical Center, Phoenix, AZ 85037, USA. Shiva.Ratuapli@bannerhealth.com
Bobba
Brijesh
B
Zafar
Haider
H
D000925:Anticoagulants / Q000627:therapeutic use*; D005260:Female; D000077425:Fondaparinux; D006400:Hematocrit; D006493:Heparin / Q000009:adverse effects*; D006629:Hirudins; D006801:Humans; D008875:Middle Aged; D010976:Platelet Count; D011134:Polysaccharides / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced*; D014463:Ultrasonography; D020246:Venous Thrombosis / Q000097:blood / Q000000981:diagnostic imaging
D000925:Anticoagulants; D006629:Hirudins; D011134:Polysaccharides; D011994:Recombinant Proteins; D006493:Heparin; D000077425:Fondaparinux; C083544:lepirudin